Theriva Biologics's total assets for Q2 2024 were $42.39M, a decrease of -13.01% from the previous quarter. TOVX total liabilities were $14.74M for the fiscal quarter, a 0.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.